Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Genetic modification of human adipose-derived stem cells for promoting wound healing.

Song SH., Lee MO., Lee JS., Jeong HC., Kim HG., Kim WS.

Animal Study on Chronic Wound, published in J Dermatol Sci (2012) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Dermatol Sci (2012)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
22472356
DOI
10.1016/j.jdermsci.2012.02.010
Citations
38

Abstract (original English)

Background Diverse growth factors secreted from human adipocyte-derived stem cells (hASCs) that support or manage adjacent cells have been studied for therapeutic potentials to a variety of pathological models. However, senescent growth arrest in hASCs during in vitro culture and subsequent defective differentiation potential, have been technical barriers to further genetic modification of hASCs for functional improvement. Objective We investigated the feasibility of long-term hASC culture to enhance their therapeutic use. Methods We used a MYC variant to generate hASCs expressing v-myc and determined their growth potential and growth factor secretion profile. We further introduced an AKT variant to generate constitutively active (CA)-Akt/v-myc hASCs. Finally, we tested the ability of promoting wound healing of medium conditioned with CA-Akt/v-myc hASCs. Results The v-myc hASCs actively proliferated longer than control hASCs. Increased secretion of vascular endothelial growth factor (VEGF) by v-myc hASCs promoted the migration potential of hASCs and vasculogenesis in co-cultured endothelial cells. Additional genetic modification of v-myc hASCs using CA-Akt further increased VEGF secretion. In addition, injection of CA-Akt/v-myc hASCs-CM into wound-mice model promoted wound healing compared to normal hASCs-CM. Conclusion Genetic modification of hASCs to stimulate secretion of gr

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdult Stem CellsAnimalsCell ProliferationCoculture TechniquesGene ExpressionGene Transfer TechniquesGenes, mycHumansMice

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research